These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 10492718)

  • 1. Flixotide Nebules: new for chronic severe asthma.
    Mukherjee SK
    Hosp Med; 1999 Jun; 60(6):442-3. PubMed ID: 10492718
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluticasone propionate powder: oral corticosteroid-sparing effect and improved lung function and quality of life in patients with severe chronic asthma.
    Nelson HS; Busse WW; deBoisblanc BP; Berger WE; Noonan MJ; Webb DR; Wolford JP; Mahajan PS; Hamedani AG; Shah T; Harding SM
    J Allergy Clin Immunol; 1999 Feb; 103(2 Pt 1):267-75. PubMed ID: 9949318
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and safety of low-dose fluticasone propionate compared with montelukast for maintenance treatment of persistent asthma.
    Meltzer EO; Lockey RF; Friedman BF; Kalberg C; Goode-Sellers S; Srebro S; Edwards L; Rickard K;
    Mayo Clin Proc; 2002 May; 77(5):437-45. PubMed ID: 12004993
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Salmeterol/fluticasone propionate (50/500 microg) in combination in a Diskus inhaler (Seretide) is effective and safe in the treatment of steroid-dependent asthma.
    Aubier M; Pieters WR; Schlösser NJ; Steinmetz KO
    Respir Med; 1999 Dec; 93(12):876-84. PubMed ID: 10653049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nebulised fluticasone.
    Todd GR
    Thorax; 2000 Apr; 55(4):346-7. PubMed ID: 10766646
    [No Abstract]   [Full Text] [Related]  

  • 6. Inhaled fluticasone propionate delivered by means of two different multidose powder inhalers is effective and safe in a large pediatric population with persistent asthma.
    Peden DB; Berger WE; Noonan MJ; Thomas MR; Hendricks VL; Hamedani AG; Mahajan P; House KW
    J Allergy Clin Immunol; 1998 Jul; 102(1):32-8. PubMed ID: 9679845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evaluation of the effect of a large volume spacer on the systemic bioactivity of fluticasone propionate metered-dose inhaler.
    Dempsey OJ; Wilson AM; Coutie WJ; Lipworth BJ
    Chest; 1999 Oct; 116(4):935-40. PubMed ID: 10531156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluticasone propionate powder administered through Diskhaler versus triamcinolone acetonide aerosol administered through metered-dose inhaler in patients with persistent asthma.
    Condemi JJ; Chervinsky P; Goldstein MF; Ford LB; Berger WE; Ayars GH; Rogenes PR; Edwards L; Pepsin PJ
    J Allergy Clin Immunol; 1997 Oct; 100(4):467-74. PubMed ID: 9338539
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of once- and twice-daily dosing of fluticasone propionate 200 micrograms per day administered by diskus device in patients with asthma treated with or without inhaled corticosteroids.
    Wolfe J; Rooklin A; Grady J; Munk ZM; Stevens A; Prillaman B; Duke S; Harding S
    J Allergy Clin Immunol; 2000 Jun; 105(6 Pt 1):1153-61. PubMed ID: 10856150
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diskus and diskhaler: efficacy and safety of fluticasone propionate via two dry powder inhalers in subjects with mild-to-moderate persistent asthma.
    Galant SP; van Bavel J; Finn A; Gross G; Pleskow W; Brown A; Hamedani AG; Harding SM
    Ann Allergy Asthma Immunol; 1999 Mar; 82(3):273-80. PubMed ID: 10094218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
    Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
    Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of fluticasone in asthma.
    Lipworth BJ
    Chest; 2000 Feb; 117(2):611-3. PubMed ID: 10669719
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhaled fluticasone in asthmatic children.
    Pescollderungg L; Radetti G; Gottardi E; Gentili L; Pietrobelli A; Boner AL
    Ann Allergy Asthma Immunol; 2002 Sep; 89(3):328-9; author reply 329. PubMed ID: 12269658
    [No Abstract]   [Full Text] [Related]  

  • 14. Is fluticasone propionate superior to the other available inhaled steroids?
    Spahn JD
    J Asthma; 1998; 35(4):307-11. PubMed ID: 9669825
    [No Abstract]   [Full Text] [Related]  

  • 15. Inhaled corticosteroids or long-acting beta-agonists alone or in fixed-dose combinations in asthma treatment: a systematic review of fluticasone/budesonide and formoterol/salmeterol.
    Frois C; Wu EQ; Ray S; Colice GL
    Clin Ther; 2009 Dec; 31(12):2779-803. PubMed ID: 20110019
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-Term Fluticasone Propionate/Formoterol Fumarate Combination Therapy Is Associated with a Low Incidence of Severe Asthma Exacerbations.
    Papi A; Mansur AH; Pertseva T; Kaiser K; McIver T; Grothe B; Dissanayake S
    J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):346-61. PubMed ID: 27104231
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effectiveness and safety of fluticasone propionate in therapy of children suffering from asthma. Part II. Safety aspects of therapy with fluticasone propionate in asthmatic children].
    Bartkowiak-Emeryk M; Breborowicz A; Emeryk A; Kulus M; Kurzawa R; Lis G; Mazurek H; Niedziela M
    Pol Merkur Lekarski; 2004; 17 Suppl 2():11-8. PubMed ID: 15688664
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pressurized metered dose inhaler (pMDI) remains the most commonly prescribed device for the delivery of inhaled asthma medications.
    Braunstein G; Sharma R
    Respir Med; 2000 Jun; 94 Suppl B():S1-2. PubMed ID: 10919678
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of inhaled corticosteroids on growth.
    Allen DB
    Pediatrics; 2001 Nov; 108(5):1234-5. PubMed ID: 11694712
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparison of patient-reported outcomes during treatment with adjustable- and fixed-dose budesonide/formoterol pressurized metered-dose inhaler versus fixed-dose fluticasone propionate/salmeterol dry powder inhaler in patients with asthma.
    O'Connor RD; Patrick DL; Parasuraman B; Martin P; Goldman M
    J Asthma; 2010 Mar; 47(2):217-23. PubMed ID: 20170333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.